Christoph Ruedig, partner at investment firm AlbionVC discusses the opportunities technology offers for advancing clinical trials.
medical tech
Clinical trials, particularly those involved in finding a Covid-19 vaccine, have never been so crucial in getting society back onto some sort of even keel. Yet they’ve also never been in such a state of transformation.
Scientists and pharmaceutical companies are racing to get coronavirus drugs into the hands of those who need them most. There is pressure from all sides to speed up a process that is, notoriously and understandably, slow moving, at the same time the whole world is scrutinising every minor detail of the industry’s response to the pandemic.